Pharmazeutische Zusammensetzung zur Cyanidvergiftung
EP4785937
5. August 2026
Anmelder: Innotesto BV 🇧🇪
Details
- Veröffentlichungs-Nr.
- EP4785937
- Anmeldetag
- 3. Februar 2025
- Veröffentlichung
- 5. August 2026
- Rechtsraum
- EP
Abstract
A kit for the treatment of cyanide poisoning includes a pharmaceutical composition of hydroxocobalamin and/or pharmaceutically acceptable hydroxocobalamin salts. This composition is formulated for mucosal, nasal, or pulmonary administration. The kit may also contain additional therapeutic agents such as sodium thiosulfate, amyl nitrite, sodium nitrite, and 4-dimethylaminophenol. The pharmaceutical composition can be provided in single-dose or multi-dose containers, with instructions for use in a drug delivery device for effective treatment.
Anmelder
- Firma
- Innotesto BV
- Land
- 🇧🇪 Belgien
Vertreten von
-
Arnold & Siedsma
Arnold & Siedsma · Den Haag